Scarica l'app Stockscreener
197.01
0.91%
1.77
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$195.24
Aprire:
$195
Volume 24 ore:
1.78M
Relative Volume:
0.76
Capitalizzazione di mercato:
$42.02B
Reddito:
$447.02M
Utile/perdita netta:
$-1.18B
Rapporto P/E:
-31.87
EPS:
-6.1812
Flusso di cassa netto:
$-906.14M
1 W Prestazione:
-3.43%
1M Prestazione:
+1.35%
6M Prestazione:
+103.35%
1 anno Prestazione:
+173.44%
Intervallo 1D:
$191.74
$198.13
Intervallo di 1 settimana:
$189.59
$206.69
Portata 52W:
$60.40
$212.75
Insmed Inc Stock (INSM) Company Profile
Nome
Insmed Inc
Settore
Industria
Telefono
908-977-9900
Indirizzo
700 US HIGHWAY 202/206, BRIDGEWATER, NJ
Confronta INSM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
Insmed Inc Stock (INSM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-04 | Iniziato | Rothschild & Co Redburn | Buy |
| 2025-10-28 | Ripresa | Cantor Fitzgerald | Overweight |
| 2025-10-20 | Iniziato | Wells Fargo | Overweight |
| 2025-08-20 | Iniziato | William Blair | Outperform |
| 2025-08-13 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-05-13 | Iniziato | Jefferies | Buy |
| 2025-02-25 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-04-23 | Iniziato | Truist | Buy |
| 2024-02-15 | Iniziato | Wolfe Research | Outperform |
| 2023-12-08 | Iniziato | Wells Fargo | Overweight |
| 2023-11-20 | Ripresa | JP Morgan | Overweight |
| 2023-07-26 | Iniziato | Guggenheim | Buy |
| 2022-12-09 | Iniziato | Mizuho | Buy |
| 2022-12-07 | Iniziato | Barclays | Overweight |
| 2022-11-18 | Iniziato | BofA Securities | Buy |
| 2022-04-27 | Iniziato | Goldman | Buy |
| 2021-12-06 | Iniziato | JP Morgan | Overweight |
| 2021-10-19 | Ripresa | Monness Crespi & Hardt | Buy |
| 2021-10-19 | Ripresa | Morgan Stanley | Overweight |
| 2021-10-08 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-04-26 | Ripresa | Credit Suisse | Outperform |
| 2020-12-17 | Iniziato | Berenberg | Buy |
| 2020-10-12 | Ripresa | Stifel | Buy |
| 2019-09-03 | Iniziato | Goldman | Buy |
| 2019-04-09 | Reiterato | H.C. Wainwright | Buy |
| 2019-02-15 | Aggiornamento | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-01-17 | Aggiornamento | Goldman | Neutral → Buy |
| 2019-01-02 | Iniziato | Canaccord Genuity | Buy |
| 2018-08-06 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2018-07-23 | Iniziato | Goldman | Neutral |
| 2018-04-23 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2018-03-21 | Iniziato | Morgan Stanley | Overweight |
| 2018-01-18 | Iniziato | Credit Suisse | Neutral |
| 2017-09-05 | Reiterato | Evercore ISI | Outperform |
| 2017-08-17 | Iniziato | Evercore ISI | Outperform |
| 2017-07-11 | Iniziato | Robert W. Baird | Outperform |
| 2016-03-15 | Iniziato | Stifel | Buy |
| 2015-11-09 | Downgrade | UBS | Buy → Neutral |
| 2015-10-06 | Reiterato | H.C. Wainwright | Buy |
| 2015-06-09 | Iniziato | Citigroup | Neutral |
| 2014-03-26 | Reiterato | HC Wainwright | Buy |
Mostra tutto
Insmed Inc Borsa (INSM) Ultime notizie
HRT Financial LP Takes Position in Insmed, Inc. $INSM - MarketBeat
Holocene Advisors LP Sells 9,616 Shares of Insmed, Inc. $INSM - MarketBeat
Insmed, Inc. $INSM Holdings Boosted by Eventide Asset Management LLC - MarketBeat
Cubist Systematic Strategies LLC Takes $28.49 Million Position in Insmed, Inc. $INSM - MarketBeat
Brevan Howard Capital Management LP Takes Position in Insmed, Inc. $INSM - MarketBeat
Insmed, Inc. $INSM Shares Sold by Bellevue Group AG - MarketBeat
Alkeon Capital Management LLC Invests $50.32 Million in Insmed, Inc. $INSM - MarketBeat
Insmed, Inc. $INSM Holdings Cut by Adage Capital Partners GP L.L.C. - MarketBeat
Annual Changes to the Nasdaq-100 Index® - GlobeNewswire Inc.
Maverick Capital Ltd. Purchases 379,008 Shares of Insmed, Inc. $INSM - MarketBeat
Insmed, Inc. $INSM Shares Sold by Federated Hermes Inc. - MarketBeat
Insmed (INSM): Assessing Valuation After a Strong Year of Share Price Gains - Yahoo Finance
Is It Too Late to Consider Insmed After a 179% Surge and DCF Upside? - Yahoo Finance
Is the Market Bullish or Bearish on Insmed Inc? - Sahm
TD Cowen Raises Price Target for Insmed (INSM) to $269 | INSM Stock News - GuruFocus
Insmed (NASDAQ:INSM) Given New $269.00 Price Target at TD Cowen - MarketBeat
Billionaire Stanley Druckenmiller is Betting $1.2 Billion in These 3 Stocks - AOL.com
HighVista Strategies LLC Reduces Stake in Insmed, Inc. $INSM - MarketBeat
Insmed, Inc. $INSM Shares Acquired by Nebula Research & Development LLC - MarketBeat
Qube Research & Technologies Ltd Buys New Position in Insmed, Inc. $INSM - MarketBeat
TD Cowen raises Insmed stock price target to $269 on strong Brinsupri launch - Investing.com Canada
WINTON GROUP Ltd Purchases New Shares in Insmed, Inc. $INSM - MarketBeat
Stempoint Capital LP Sells 25,481 Shares of Insmed, Inc. $INSM - MarketBeat
Insmed (Nasdaq: INSM) highlights TPIP, brensocatib data in ERS 2025 ALERT session - Stock Titan
Resolute Capital Asset Partners LLC Makes New Investment in Insmed, Inc. $INSM - MarketBeat
Hsbc Holdings PLC Has $1.30 Million Stake in Insmed, Inc. $INSM - MarketBeat
B Group Inc. Sells 107,500 Shares of Insmed, Inc. $INSM - MarketBeat
Hood River Capital Management LLC Reduces Holdings in Insmed, Inc. $INSM - MarketBeat
Insmed, Inc. $INSM Stock Holdings Decreased by Kennedy Capital Management LLC - MarketBeat
Insmed, Inc. $INSM Shares Sold by Invesco Ltd. - MarketBeat
Jump Financial LLC Takes Position in Insmed, Inc. $INSM - MarketBeat
Bollard Group LLC Acquires New Holdings in Insmed, Inc. $INSM - MarketBeat
Marshall Wace LLP Acquires 417,124 Shares of Insmed, Inc. $INSM - MarketBeat
Quantbot Technologies LP Invests $2.22 Million in Insmed, Inc. $INSM - MarketBeat
Insmed (NASDAQ:INSM) Upgraded to "Strong-Buy" at Rothschild Redb - MarketBeat
Affinity Asset Advisors LLC Increases Holdings in Insmed, Inc. $INSM - MarketBeat
Dir Sharoky Files To Sell 20,000 Of Insmed Inc [INSM] - TradingView
Is Insmed Stock Built to Withstand a Pullback? - Trefis
Insmed Insider Sold Shares Worth $2,199,915, According to a Recent SEC Filing - marketscreener.com
INSMED Chair and CEO William Lewis Sells Over 10,000 Shares - TradingView
Schroder Investment Management Group Reduces Position in Insmed, Inc. $INSM - MarketBeat
Diametric Capital LP Purchases Shares of 7,757 Insmed, Inc. $INSM - MarketBeat
Will Insmed Incorporated (IM8N) stock outperform small cap peersJuly 2025 Selloffs & Expert-Curated Trade Recommendations - Newser
How Insmed Incorporated (IM8N) stock compares with tech leadersMarket Trend Review & Safe Capital Preservation Plans - Newser
Will Insmed Incorporated stock see PE expansionJuly 2025 Highlights & Reliable Breakout Forecasts - Newser
Insmed reports inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Rothschild & Co Redburn Initiates Coverage on Insmed With Buy Rating, $263 Price Target - marketscreener.com
Panagora Asset Management Inc. Sells 157,126 Shares of Insmed, Inc. $INSM - MarketBeat
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Prime Publishers, Inc.
Rothschild Redburn initiates Insmed stock with Buy rating, $263 target By Investing.com - Investing.com Canada
How Insmed Incorporated (IM8N) stock responds to job market shiftsOptions Play & Expert-Curated Trade Recommendations - Newser
Insmed Inc Azioni (INSM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):